(TRACT) Teract S.A. - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock •

TRACT: Garden, Pet, Food, Fresh, Produce, Organic

Teract S.A. (PA:TRACT) is a European retail operator with a diversified portfolio of brands across garden centers, pet care, and fresh, local, and organic produce. The company operates 1,597 stores under its Jardiland, Gamm vert, Delbard, and Jardinerie du Terroir brands, focusing on gardening supplies, pet products, and seasonal items. Additionally, it has expanded into the fresh, local, and organic food sector through its Frais dIci and Bio&Co brands, catering to the growing demand for sustainable and organic products. Headquartered in Paris, France, Teract has established itself as a key player in niche retail segments, leveraging its brand portfolio to capture market share in Europes specialty retail market.

As of the latest data, Teracts stock is trading at 0.92 EUR, with a 20-day average volume of 4,692 shares. The stocks short-term trend, indicated by its SMA20 of 0.91, aligns closely with its current price, while its SMA50 of 0.96 suggests recent downward pressure. The SMA200 of 0.81 reflects a longer-term downtrend, with the stock trading below this key support level. The ATR of 0.03 highlights low volatility, suggesting limited price movement in the near term.

From a fundamental perspective, Teracts market cap stands at 67.88M EUR, with a P/B ratio of 0.25, indicating undervaluation relative to its book value. The P/S ratio of 0.07 reflects a low valuation compared to its revenue, while the negative RoE of -31.67 underscores significant profitability challenges. The absence of P/E and forward P/E ratios suggests either a lack of profitability or limited analyst coverage.

3-Month Forecast: Based on the convergence of and , Teracts stock is expected to remain range-bound with limited upside. The SMA200 at 0.81 and ATR of 0.03 suggest a potential trading range of 0.88 to 0.96 over the next three months. However, the negative RoE and lack of profitability metrics may weigh on investor sentiment, capping any meaningful rally. The low P/S ratio could attract value investors, but the stocks fundamentals and technical indicators point to a cautious outlook.

Additional Sources for TRACT Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

TRACT Stock Overview

Market Cap in USD 72m
Sector Consumer Cyclical
Industry Specialty Retail
GiC Sub-Industry Other Specialty Retail
IPO / Inception

TRACT Stock Ratings

Growth 5y -44.3%
Fundamental -27.4%
Dividend 0.0%
Rel. Strength Industry 34.9
Analysts -
Fair Price Momentum 0.62 EUR
Fair Price DCF 0.55 EUR

TRACT Dividends

No Dividends Paid

TRACT Growth Ratios

Growth Correlation 3m -73.9%
Growth Correlation 12m 36.9%
Growth Correlation 5y -88.5%
CAGR 5y -60.48%
CAGR/Max DD 5y -0.63
Sharpe Ratio 12m -0.59
Alpha -11.79
Beta 1.82
Volatility 50.44%
Current Volume 1.5k
Average Volume 20d 1.3k
What is the price of TRACT stocks?
As of March 14, 2025, the stock is trading at EUR 0.89 with a total of 1,501 shares traded.
Over the past week, the price has changed by -2.64%, over one month by +0.68%, over three months by -20.18% and over the past year by +44.77%.
Is Teract S.A. a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Teract S.A. (PA:TRACT) is currently (March 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -27.37 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of TRACT as of March 2025 is 0.62. This means that TRACT is currently overvalued and has a potential downside of -30.34%.
Is TRACT a buy, sell or hold?
Teract S.A. has no consensus analysts rating.
What are the forecast for TRACT stock price target?
According to ValueRays Forecast Model, TRACT Teract S.A. will be worth about 0.7 in March 2026. The stock is currently trading at 0.89. This means that the stock has a potential downside of -21.35%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 0.7 -21.3%